The DOI matches its Crossref record.
Syk tyrosine kinase required for mouse viability and B-cell development
Abstract
The Syk cytoplasmic protein-tyrosine kinase has two amino-terminal SH2 domains and a carboxy-terminal catalytic domain. Syk, and its close relative ZAP-70, are apparently pivotal in coupling antigen- and Fc-receptors to downstream signalling events. Syk associates with activated Fc receptors, the T cell receptor complex and the B-cell antigen-receptor complex (BCR) in immature and mature B lymphocytes. On receptor activation, the tandem SH2 domains of Syk bind dual phosphotyrosine sites in the conserved ITAM motifs of receptor signalling chains, such as the immunoglobulin alpha and beta-chains of the BCR, leading to Syk activation. Here we have investigated Syk function in vivo by generating a mouse strain with a targeted mutation in the syk gene. Homozygous syk mutants suffered severe haemorrhaging as embryos and died perinatally, indicating that Syk has a critical role in maintaining vascular integrity or in wound healing during embryogenesis. Analysis of syk-/- lymphoid cells showed that the syk mutation impaired the differentiation of B-lineage cells, apparently by disrupting signalling from the pre-BCR complex and thereby preventing the clonal expansion, and further maturation, of pre-B cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Functional deficiencies in any one of these three family members of the protein-tyrosine kinase family result in defective or aberrant function and impaired development of B cells (10-12”
From AKT Induces Transcriptional Activity of PU.1 through Phosphorylation-mediated Modifications within Its Transactivation Domain (2001) · cites this paper as [11]
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 31
- Taniguchi, T. et al. J. biol. Chem. 266, 15790–15796 (1991). · DOI
- Chan, A. C., Iwashima, M., Turck, C. W. & Weiss, A. Cell 71, 649–662 (1992). · DOI
- DeFranco, A. L. Curr. Opin. cell. Biol. 7, 163–175 (1995). · DOI
- Takata, M. et al. EMBO J. 13, 1341–1349 (1994). · DOI · Paper page
- Durden, D. L. & Liu, Y. B. Blood 84, 2102–2108 (1994). · DOI
- Chan, A. C. et al. J. Immun. 152, 4758–4766 (1994). · DOI
- Hutchcroft, J. E., Harrison, M. L. & Geahlen, R. L. J. biol. Chem. 267, 8613–8619 (1992). · DOI
- Rowley, R. B., Burkhardt, A. L., Chao, H.-G., Matsueda, G. R. & Bolen, J. B. J. biol. Chem. 270, 11590–11594 (1995). · DOI
- Leveen, P. et al. Genes Dev. 8, 1875–1887 (1994). · DOI
- Soriano, P. Genes Dev. 8, 1888–1896 (1994). · DOI
- Taniguchi, T. et al. J. biol. Chem. 268, 2277–2279 (1993). · DOI
- Rezaul, K., Yanagi, S., Sada, K., Taniguchi, S. & Yamamura, H. Fibrosis Hemostas. 72, 937–941 (1995).
- Clark, E. A., Shattil, S. J., Ginsberg, M. H., Bolen, J. & Brugge, J. S. J. biol. Chem. 269, 28859–28864 (1994). · DOI
- Sninkai, Y. et al. Cell 68, 855–867 (1992). · DOI
- Arpaia, E., Shahar, M., Dadi, H., Cohen, A. & Roifman, C. M. Cell 76, 947–958 (1994). · DOI
- Chan, A. C. et al. Science 264, 1599–1601 (1994). · DOI
- Hayakawa, K., Hardy, R. R., Herzenberg, L. A. & Herzenberg, L. A. J. exp. Med. 161, 1554–1568 (1985). · DOI
- Hardy, R. R., Carmack, C. E., Shinton, S. A., Kemp, J. D. & Hayakawa, K. J. exp. Med. 173, 1213–1225 (1991). · DOI
- Kitamura, D. et al. Cell 69, 823–831 (1992). · DOI · Paper page
- Misener, V., Downey, G. P. & Jongstra, J. Int. Immun. 3, 1129–1136 (1991). · DOI
- Karasuyama, H., Kudo, A. & Melchers, F. J. exp. Med. 172, 969–979 (1992). · DOI
- Decker, D. J., Boyle, N. E., Koziol, J. & Klinman, N. R. J. Immun. 146, 350–359 (1991). · DOI
- Spanopoulou, E. et al. Genes Dev. 8, 1030–1042 (1994). · DOI
- Young, F. et al. Genes Dev. 8, 1043–1057 (1994). · DOI
- Papavasiliou, F., Misulovin, Z., Suh, H. & Nussenzweig, M. C. Science 268, 408–411 (1995). · DOI
- Gu, H., Kitamura, D. & Rajewsky, K. Cell 65, 47–54 (1991). · DOI
- Haasner, D., Rolink, A. & Melchers, F. Int. Immun. 6, 21–30 (1994). · DOI
- Joyner, A. L. in Gene targeting. A practical approach (IRL, Oxford, 1993).
- Mallick, C. A., Dudley, E. C., Viney, J. L., Owen, M. J. & Hayday, A. C. Cell 73, 513–519 (1993). · DOI
- Carlsson, L., Overmo, C. & Holmberg, D. Eur. J. Immun. 22, 71–78 (1992). · DOI
- Chukwuocha, R. U., Hartman, A. B. & Feeney A. J. Immunogenet. 40, 76–78 (1994). · DOI
Cited by
Sorted by citations
The SYK tyrosine kinase: A crucial player in diverse biological functions
Mócsai, A., Ruland, J., & Tybulewicz, V. L. J. (2010) · Nature Reviews Immunology · doi:10.1038/nri2765 · Cited by 1,368
Phospholipase Cγ2 Is Essential in the Functions of B Cell and Several Fc Receptors
Wang, D., Feng, J., Wen, R., Marine, J.-C., Sangster, M. Y., Parganas, E., Hoffmeyer, A., Jackson, C. W., Cleveland, J. L., Murray, P. J., et al. (2000) · Immunity · doi:10.1016/s1074-7613(00)00005-4 · Cited by 475
Syk is required for integrin signaling in neutrophils
Mócsai, A., Zhou, M., Meng, F., Tybulewicz, V. L., & Lowell, C. A. (2002) · Immunity · doi:10.1016/s1074-7613(02)00303-5 · Cited by 421
Kinase inhibition in autoimmunity and inflammation
Zarrin, A. A., Bao, K., Lupardus, P., & Vucic, D. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-020-0082-8 · Cited by 431
Mueller, H., Stadtmann, A., Van Aken, H., Hirsch, E., Wang, D., Ley, K., & Zarbock, A. (2010) · Blood · doi:10.1182/blood-2009-11-254185 · Cited by 164
Metadata
- Authors
- Cheng, A. M., Rowley, B., Pao, W., Hayday, A., Bolen, J. B., & Pawson, T.
- Venue
- Nature
- Published
- 1995-11-16
- Volume
- 378
- Issue
- 6554
- Pages
- 303-306
- ISSN
- 0028-0836
- 1476-4687
- Cited by
- 528
- References
- 0
- Language
- en
- Update notices
- correction (1996-02-15)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review